These analyses indicate that smokers and COPD patients exhibit unique NK cell populations marked primarily by lower CD56 expression, high CD57 expression (activation and maturity marker), and high expression activation markers NKp46 and NKp44 (Fig. 4). This evidence concerns the gene NCAM1 and chronic obstructive pulmonary disease.